Rethink & Redesign Your Life Sciences Talent Acquisition Strategy To Enhance TA Efficiency Today & Transform Your Business Impact Tomorrow
100+ other senior and strategic TA leaders came together for three full days where they navigated the impact of a more hesitant biopharma market in 2023.
25+ case studies were explored, of how pre-commercial biotechs, established biopharma organizations, and big pharma are breaking away from traditional thinking to redesign their approach to strategic talent acquisition and transform the value that the recruitment function provides to the wider business.
Following the intensity of the biopharma candidate market the past two years, this was a great opportunity to uncover how your peers are doing more with less, building highly effective talent management strategies into talent acquisition operations, and investing in the time-and-money saving technology that will transform TA impact when high-volume hiring ramps up again.
Learn about Takeda’s robust employee value proposition (EVP) which leverages data to cultivate a sense of purpose, enabling them to unleash the power of employer branding.
Bristol Myers Squibb’s approach to skills-based hiring which helped decrease time-tofill
and increased visibility to all candidates.
The toolkit developed by Olema Oncology, including a scalable applicant tracking system and compliant recruitment process across all levels, which led to 50% reduced time-to-fill and 80% increased offer acceptance from 2022 to 2023.
Discover how BigHat Biosciences adopted a consultative approach to TA which led to an offer acceptance rate of 100% in Q4 of 2022, as well as fifteen full-time hires in Q1 2023
See First-Hand What Our Past Attendees Have To Say:
" A great opportunity to network with TA colleagues and learn what other organizations are doing well and where they are struggling so we can help each other win. "
Marissa MacGauley, Director, Talent Acquisition, Cell Therapy, Bristol Myers Squibb